| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/05/2010 | CN1547589B Gene controlling life span of leaves in plants and method for controlling life span of plants using the gene |
| 05/05/2010 | CN1500806B HIV-lgp160 membrane protein, preparing method and uses thereof |
| 05/05/2010 | CN1446261B Modified cytokines for use in cancer therapy |
| 05/05/2010 | CN1420924B Recombinant human alpha-L-iduronidase, method for producing and purifying same and method for treating disorders including deficiency thereof |
| 05/05/2010 | CN1387572B Plant reglatory sequences for selective control of gene expression |
| 05/05/2010 | CN1376204B Flex seed specific promoters |
| 05/05/2010 | CN1325959B Genes from genome |
| 05/05/2010 | CN101702919A Mammalian-type glycosylation in plants by expression of non-mammalian glycosyltransferases |
| 05/05/2010 | CN101702909A Yield enhancement in plants by modulation of maize MADS box transcription factor ZMM28 |
| 05/05/2010 | CN101702881A Use of selected lactic acid bacteria for reducing atherosclerosis |
| 05/05/2010 | CN101701219A cDNA for encoding rabbit hepatocyte growth factor and expression vector and application thereof |
| 05/05/2010 | CN101701038A Plant low temperature growth associated protein, code genes and application thereof |
| 05/05/2010 | CN101701037A Transporter protein for regulating and controlling salt resistance and drought resistance of plant and encoding gene and application thereof |
| 05/05/2010 | CN101701036A Antifungal peptide and preparation method and application thereof |
| 05/05/2010 | CN101701035A Protein GaTPSP relevant to drought resistance of plants, coding gene and application thereof |
| 05/05/2010 | CN101701034A Method for preparing high-purity nisin |
| 05/05/2010 | CN101701033A Methods for preparing antigen, antibody and sample of Eperythrozoon suis |
| 05/04/2010 | USRE41318 Plant promoter sequences and methods of use for same |
| 05/04/2010 | US7709712 Plants and seeds of corn variety CV194481 |
| 05/04/2010 | US7709711 Plants and seeds of corn variety CV941589 |
| 05/04/2010 | US7709710 Plants and seeds of corn variety CV016780 |
| 05/04/2010 | US7709709 Plants and seeds of corn variety CV334995 |
| 05/04/2010 | US7709707 Inbred corn line BS315 |
| 05/04/2010 | US7709701 Genetic manipulation of condensed tannins |
| 05/04/2010 | US7709698 Transcription factor stress-related proteins and methods of use in plants |
| 05/04/2010 | US7709695 Transgenic mouse expressing arctic mutation E693G |
| 05/04/2010 | US7709628 Modulation of STAT5 expression |
| 05/04/2010 | US7709623 Xenorhabdus TC proteins and genes for pest control |
| 05/04/2010 | US7709622 Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis |
| 05/04/2010 | US7709621 Vectors with modified protease-dependent tropism |
| 05/04/2010 | US7709618 BTL-II nucleic acids |
| 05/04/2010 | US7709610 As an antagonist that inhibits immunoglobulin secretion; autoimmune disorders; antiproliferative , anticarcinogenic and antiarthritic agents; inflammatory bowel disease |
| 05/04/2010 | US7709609 Tumor suppressor gene, p47ING3 |
| 05/04/2010 | US7709607 solubility of the variant is improved by at least 3-fold relative to residues 110-244 of human adiponectin; increased soluble expression and stability, lower immunogenicity, and improved pharmacokinetics and/or pharmacodynamics |
| 05/04/2010 | US7709606 Interacting polypeptide comprising a heptapeptide pattern and a cellular penetration domain |
| 05/04/2010 | US7709605 for modulating growth of a tissue, such as bone, cartilage, muscle, fat, and/or neuron; comprising an altered Growth differentiation factor 11 (GDF11)-binding domain of an ActRII receptor |
| 05/04/2010 | US7709604 In vitro translation system for incorporation of 5-hydroxytryptophan opal stop codon; directed protein evolution |
| 05/04/2010 | US7709603 PRO1190 polypeptides |
| 05/04/2010 | US7709602 PRO1078 polypeptides |
| 05/04/2010 | US7709600 Interaction between the VHL tumor suppressor and hypoxia inducible factor, and assay methods relating thereto |
| 05/04/2010 | US7709455 administering a VEGFR modulating agent that comprises placental growth factor; a growth factor that binds and activates Flt-1 such as PIGF or VEGF-B, an anti-Flt-1 agonistic antibody or a small molecule agonist |
| 05/04/2010 | US7709446 Multifunctional protease inhibitors and their use in treatment of disease |
| 05/04/2010 | US7709441 Using carbonic anhydrase related protein (CARP) as tool in treatment and prevention of calcium release disorders |
| 05/04/2010 | US7709439 one bioactive polymer comprised of at least one peptide and/or protein subunit and at least one polysaccharide and/or proteoglycan subunit; and biocompatible polymer; providing a scaffold for cell migration and attachment |
| 05/04/2010 | US7709270 Using platelete derived growth factor as tool in detection of modulators for prevention and treatment of cell proliferative disorders |
| 05/04/2010 | US7709253 comprising a reporter polynucleotide that comprises a GAL4, promoter sequences, activator fusion protein ; anticancer, antiosteoporosis, gene therapy and hormone replacement treatments |
| 05/04/2010 | US7709239 Expression vector comprising nucleotide sequences coding oxidoreductase for use in generation and propagation of oils containing long-chain polyunsaturated fatty acids in yeast |
| 05/04/2010 | US7709237 Crystal structure of CMY-10, a β-lactamase causing antibiotic resistance with extended-substrate spectrum |
| 05/04/2010 | US7709229 Culturing mouse C127 cells under control of the metallothionein-1 promoter to express recombinant human growth hormone and in a Dulbecco's Modified Eagle's Medium containing trace amounts of zinc sulfate, copper sulfate and ferric citrate |
| 05/04/2010 | US7709228 Single-chain polypeptide fusion comprising functional binding, translocation and clostridial neurotoxin heavy chain domain for use as therapeutic agents and/or transporter molecules |
| 05/04/2010 | US7709227 elastin-like peptides (ELP) spider structure complex including multi-leg moieties comprising ELP fusion proteins capable of forming covalent disulfide bonds; employed in peptide production and purification and/or to enhance protelytic resistance of a protein or peptide moiety in a fusion construct |
| 05/04/2010 | US7709220 Methods of monitoring treatment of BAFF-R related disease |
| 05/04/2010 | US7709218 Tumor necrosis factor receptors 6α and 6β |
| 05/04/2010 | US7709217 Mixture comprising hemopoietic cytokine specific immunnoglobulin for use in detection of infection and immunololgical disorders |
| 05/04/2010 | US7709216 Methods for preventing or reducing ischemia/reperfusion induced myocardial cell death |
| 05/04/2010 | US7709214 Using antibody specific blocking agents to treat and prevent infection, cell proliferative and immunosuppressive disorders |
| 05/04/2010 | US7709211 Proteins expressed by mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines |
| 05/04/2010 | US7709009 Immunogenic compositions for streptococcus pyogenes |
| 05/04/2010 | US7709008 An recombinant serine-aspartate repeat (Sdr) protein from Staphylococcus epidermidis which is cell-wall associated, wherein the protein comprises the amino acid sequence 10-1742 of SEQ ID NO: 4.; multicomponent vaccines; coating polymericbiomaterials; catheters; prosthetics; nucleic acid probes |
| 05/04/2010 | US7709007 Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences |
| 05/04/2010 | US7709006 Hepatitis-C virus testing |
| 05/04/2010 | US7709004 Method of producing an HIV-1 immune response |
| 05/04/2010 | US7709003 Method of producing an HIV-1 immune response |
| 05/04/2010 | US7709000 Using MG1(mucin) specific immunoglobulins to target therapeutic agents to tumor cells |
| 05/04/2010 | US7708998 Methods of inhibiting unwanted cell proliferation using hedgehog antagonists |
| 05/04/2010 | US7708996 Tumor necrosis factor receptor specific immunoglobulins for use in treatment and prevention of cancers, autoimmune, viral, inflammatory, graft vs host and nervous system disorders |
| 05/04/2010 | US7708992 Methods for producing antibody compositions with increased ADCC |
| 05/04/2010 | US7708984 Using immunoglobulin specific to adenoid expressed chemokine (ADEC) for prevention and treatment of cell proliferative, glandular and viral infection |
| 05/04/2010 | CA2571339C Stable cell lines expressing herg |
| 05/04/2010 | CA2514158C Enhanced production of clotting factors by cryoprecipitation |
| 05/04/2010 | CA2448863C Increased and sustained in vivo gene expression using a nucleic acid, histone, and amphipathic compound composition |
| 05/04/2010 | CA2418395C Protein induced by homogeneous blood transfusion and dna encoding the same |
| 05/04/2010 | CA2367636C Fusion proteins |
| 05/04/2010 | CA2318494C Angiotensin converting enzyme inhibitor |
| 05/04/2010 | CA2299624C Mammalian cytokine receptor - 11 |
| 05/04/2010 | CA2281920C Compositions and methods for modulating cellular nf-.kappa.b activation |
| 05/04/2010 | CA2223503C Transferrin receptor genes |
| 05/04/2010 | CA2172398C Methods and products for controlling immune responses in mammals |
| 05/04/2010 | CA1341604C Dna sequences, recombinant dna molecules and processes for producing human fibroblast interferon-like polypeptides |
| 04/29/2010 | WO2010048615A2 Human ebola virus species and compositions and methods thereof |
| 04/29/2010 | WO2010048522A1 Thermostable cellulase and methods of use |
| 04/29/2010 | WO2010048308A2 Natriuretic polypeptides |
| 04/29/2010 | WO2010048306A1 High-throughput assay for evaluating dipeptidyl peptidase i activity |
| 04/29/2010 | WO2010048278A1 Prostate stem cells and uses thereof |
| 04/29/2010 | WO2010048252A1 Lawsonia intracellularis vaccines |
| 04/29/2010 | WO2010047839A1 Modified plant virus particles and uses therefor |
| 04/29/2010 | WO2010047829A1 Mutant hepatitis c virus e2 polypeptides for hcv treatment |
| 04/29/2010 | WO2010047519A2 Heart tissue specific gene mmh1 |
| 04/29/2010 | WO2010047062A1 Rab6kifl/kif20a epitope peptide and vaccines containing the same |
| 04/29/2010 | WO2010047028A1 Screening method of anti-lung or esophageal cancer compounds |
| 04/29/2010 | WO2010046944A1 Proteases targeting agents |
| 04/29/2010 | WO2010046778A2 Novel shigella frotein antigens and methods |
| 04/29/2010 | WO2010046592A2 Use of isolated polypeptides having antigenic properties against mycoplasma pneumoniae, and of corresponding polynucleotides and antibodies |
| 04/29/2010 | WO2010046588A1 Peptide derivatives and use thereof as carriers for molecules in the form of conjugates |
| 04/29/2010 | WO2010046540A1 Nucleic acid binding peptide |
| 04/29/2010 | WO2010046357A1 Amylin derivatives |
| 04/29/2010 | WO2010045570A1 Methods and compositions for inhibiting propagation of viruses using recombinant tetherin constructs |
| 04/29/2010 | WO2010024704A3 A gammacarboxyglutamate-rich protein, methods and assays for its detection, purification and quantification and uses thereof |
| 04/29/2010 | WO2010022462A3 Mutant bacterial glycoproteins and uses thereof |
| 04/29/2010 | WO2010019717A3 Combination therapy of hiv fusion/entry inhibitors targeting gp41 |